Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Characterizing Alzheimer's disease using a hypometabolic convergence index.

Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 1;56(1):52-60. doi: 10.1016/j.neuroimage.2011.01.049. Epub 2011 Jan 27.

2.

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Review.

3.

[Current topics about mild cognitive impairment (MCI)].

Yamamoto Y.

Seishin Shinkeigaku Zasshi. 2011;113(6):584-92. Review. Japanese.

PMID:
21815470
4.

Tracking Alzheimer's disease.

Thompson PM, Hayashi KM, Dutton RA, Chiang MC, Leow AD, Sowell ER, De Zubicaray G, Becker JT, Lopez OL, Aizenstein HJ, Toga AW.

Ann N Y Acad Sci. 2007 Feb;1097:183-214. Review.

5.

Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM; The Alzheimer's Disease Neuroimaging Initiative.

Behav Neurol. 2009;21(1):3-12. doi: 10.3233/BEN-2009-0230. Review.

6.

Applications of neuroimaging to disease-modification trials in Alzheimer's disease.

Fleisher AS, Donohue M, Chen K, Brewer JB, Aisen PS; Alzheimer's Disease Neuroimaging Initiative.

Behav Neurol. 2009;21(1):129-36. doi: 10.3233/BEN-2009-0241. Review.

Supplemental Content

Support Center